This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Efficacy and Safety of Tenapanor in Patients With Constipation Predominant Irritable Bowel Syndrome: A 12‐week, Double‐Blind, Placebo‐Controlled, Randomized Phase 3 Trial: 421. (October 2017)
Record Type:
Journal Article
Title:
Efficacy and Safety of Tenapanor in Patients With Constipation Predominant Irritable Bowel Syndrome: A 12‐week, Double‐Blind, Placebo‐Controlled, Randomized Phase 3 Trial: 421. (October 2017)
Main Title:
Efficacy and Safety of Tenapanor in Patients With Constipation Predominant Irritable Bowel Syndrome: A 12‐week, Double‐Blind, Placebo‐Controlled, Randomized Phase 3 Trial